International Journal of Drug Policy
Volume 21, Issue 1 , Pages 20-27 , January 2010

Syphilis in drug users in low and middle income countries

  • Lara S. Coffin

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Beth Israel Medical Center, New York, NY, USA
    • Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY, USA
    • ,
  • Ashley Newberry

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Beth Israel Medical Center, New York, NY, USA
    • ,
  • Holly Hagan

      Affiliations

    • Center for Drug Use and HIV Research, National Development and Research Institutes, Inc., New York, NY, USA
    • ,
  • Charles M. Cleland

      Affiliations

    • Center for Drug Use and HIV Research, National Development and Research Institutes, Inc., New York, NY, USA
    • ,
  • Don C. Des Jarlais

      Affiliations

    • Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY, USA
    • Center for Drug Use and HIV Research, National Development and Research Institutes, Inc., New York, NY, USA
    • ,
  • David C. Perlman

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Beth Israel Medical Center, New York, NY, USA
    • Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY, USA
    • Center for Drug Use and HIV Research, National Development and Research Institutes, Inc., New York, NY, USA
    • Corresponding Author InformationCorresponding author at: Beth Israel Medical Center, 350 East 17th Street, 19th Floor, New York, NY 10003, USA. Tel.: +1 212 844 8549; fax: +1 212 844 8556.

Received 11 June 2008 ,Revised 20 October 2008 ,Accepted 26 February 2009.

References 

  1. Abdala N, Carney JM, Durante AJ, Klimov N, Ostrovski D, Somalí AM, et al. Estimating the prevalence of syringe-borne and sexually transmitted disease among injection drug users in St. Petersburg, Russia. International Journal of STD & AIDS. 2003;14(10):697–703
  2. Altaf A, Shah SA, Zaidi NA, Memon A, Nadeemur-Rehman , Wray N. High risk behaviors of injection drug users registered with harm reduction programme in Karachi, Pakistan. Harm Reduction Journal. 2007;4(1):7
  3. Azim T, Islam MN, Bogaerts J, Mian MAH, Sarker MS, Fattah KR, et al. Prevalence of HIV and syphilis among high-risk groups in Bangladesh. AIDS. 2000;14(2):210–211
  4. Azim T, Bogarts J, Yirrell DL, Banerjea AC, Sarker MS, Ahmed G, et al. Injecting drug users in Bangladesh: Prevalence of syphilis. Hepatitis, HIV and HIV subtypes. AIDS. 2002;16(1):121–123
  5. Azim T, Alam MS, Rahman M, Sarker MS, Ahmed G, Khan MR, et al. Impending concentrated HIV epidemic among injecting drug users in Central Bangladesh. International Journal of STD & AIDS. 2004;15(4):280–282
  6. Azim T, Chowdhury EI, Reza M, Ahmed M, Uddin MT, Khan R, et al. Vulnerability to HIV infection among sex workers and non-sex worker female injecting drug users in Dhaka, Bangladesh: Evidence from the baseline survey of a cohort study. Harm Reduction Journal. 2006;3:33
  7. Baqi S, Nabi N, Hasan SN, Khan AJ, Pasha O, Kayani N, et al. HIV antibody seroprevalence and associated risk factors in sex workers, drug users, and prisoners in SINDO, Pakistan. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(1):73–79
  8. Beyrer C, Razak MH, Jittiwutikarn J, Suriyanon V, Vongchak T, Srirak N, et al. Methamphetamine users in Northern Thailand: Changing demographics and risks for HIV and STD among treatment-seeking substance abusers. International Journal of STD & AIDS. 2004;15(10):697–704
  9. Browne R, Nwokolo N, Boag F. Effect of treatment for sexually transmitted disease on HIV transmission. Journal of HIV Therapy. 2003;8(3):67–71
  10. Buchacz K, Greenberg A, Onorato I, Janssen R. Syphilis epidemics and human immunodeficiency virus (HIV) incidence among men who have sex with men in the United States: Implications for HIV prevention. Sexually Transmitted Diseases. 2005;32(Suppl. 10):S73–S79
  11. Carey MP, Ravi V, Chandra PS, Desai A, Neal DJ. Screening for sexually transmitted infections at a DeAddictions service in south India. Drug and Alcohol Dependence. 2006;82(2):127–134
  12. Chen XS, Yin YP, Liang GJ, Gong XD, Li HS, Poumerol G, et al. Sexually transmitted infections among female sex workers in Yunnan, China. AIDS Patient Care and STDs. 2005;19(12):853–860
  13. de Carvalho HB, Mesquita F, Massad E, Bueno RC, Lopes GT, Ruiz MA, et al. HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1996;12(1):84–92
  14. Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Abdul-Quader A, Heckathorn DD, et al. Convergente of HIV seroprevalence among injecting and non-injecting drug users in New York city. AIDS. 2007;21(2):231–235
  15. Des Jarlais DC, Hagan H, Arasteh K, McKnight C, Perlman D, Friedman SR. Herpes simples virus-2 and HIV among noninjection drug users in New York city. Sexually Transmitted Diseases. 2007;34(11):923–927
  16. Dowe G, Smikle MF, Thesiger C, Williams E. Bloodborne sexually transmitted infections in patients presenting for substance abuse treatment in Jamaica. Sexually Transmitted Diseases. 2001;28(5):266–269
  17. El Ghazzawi E, Drew L, Hamdy L, El Sherbini E, El Din Aly Sedek S, Saleh E. Intravenous drug addicts: A high risk group for infection with human immunodeficiency virus, hepatitis virus, cytomegalovirus and bacterial infections in Alexandria, Egypt. Journal of the Egyptian Public Health Association. 1995;70(1–2):127–150
  18. Frost SDW, Brouwer KC, Firestone Cruz MA, Ramos R, Ramos ME, Lozada RM, et al. Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: Recruitment dynamics and impact on estimates of HIV and syphilis prevalence. Journal of Urban Health. 2007;83(Suppl. 6):i83–i97
  19. Go VF, Frangakis C, Nam LV, Bergenstrom A, Sripaipan T, Zenilman JM, et al. High HIV sexual behaviors and sexually transmitted disease prevalence among injection drug users in Northern Vietnam: Implications for a generalized HIV epidemic. Journal of Acquired Immune Deficiency Syndromes. 2006;42(1):108–115
  20. Greenblatt RM, Lukehart SA, Plumier FA, Quinn TC, Critchlow CW, Ashley RL, et al. Genital ulceration as a risk factor for Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS. 1988;2(1):47–50
  21. Hahn RA, Onorato IM, Jones TS, Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. Journal of the American Medical Association. 1989;261(18):2677–2684
  22. Kalichman SC, Nelly JA, Sikkema KJ, Koslov AP, Shaboltas A, Granskaya J. The emerging AIDS crisis in Russia: Review of enabling factors and prevention needs. International Journal of STD & AIDS. 2000;11(2):71–75
  23. Karapetyan AF, Sokolovsky YV, Araviyskaya ER, Zvartau EE, Ostrovsky DV, Hagan H. Syphilis among intravenous drug-using population: Epidemiological situation in St. Petersburg, Russia. International Journal of STD & AIDS. 2002;13(9):618–623
  24. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edwin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet. 2001;357(9266):1397–1401
  25. Kurbanov F, Kondo M, Tanaka Y, Zalalieva M, Giasova G, Shima T, et al. Human immunodeficiency virus in Uzbekistan: Epidemiological and genetic analyses. AIDS Research and Human Retroviruses. 2003;19(9):731–738
  26. Liu H, Grusky O, Li X, Ma E. Drug users: A potentially important bridge population in the transmission of sexually transmitted diseases, including AIDS, in China. Sexually Transmitted Diseases. 2006;33(2):111–117
  27. Lyles CM, Kay LS, Crepaz N, Herbst JH, Passin WF, Kim AS, et al. Best-evidence interventions: Findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. American Journal of Public Health. 2007;97(1):133–143
  28. Mandell GL, Douglas RG, Bennett JE, Dolin R. Infectious diseases and their etiological agents. In:  Mandell GL,  Dolin R,  Bennett JE editor. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 5th ed.. Philadelphia, PA, Churchill, Livingstone: Elsevier; 2005;p. 2778–2780
  29. Nelson KE, Vlahov D, Cohn S, Odunmbaku M, Lindsay A, Antohony JC, et al. Sexually transmitted diseases in a population of intravenous drug users: Association with seropositivity to the Human Immunodeficiency Virus (HIV). Journal of Infectious Diseases. 1991;164(3):457–463
  30. Ostrovskii DV. The clean syringe and HIV infection. A clean syringe can be obtained by any drug addict in a bus stationed in places of active drug trading. Zh Mikrobiol Epidemiol Immunobiol. 1999;(January–February (1)):118–119(Russian)
  31. Palacios R, Jiménez-Oñate F, Aguilar M, Galindo MJ, Rivas P, Ocampo A, et al. Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV infected patients. Journal of Acquired Immune Deficiency Syndromes. 2007;44(3):356–359
  32. Panda S, Chatterjee A, Sarkar S, Jalan KN, Maitra T, Mukherjee S, et al. Injection drug use in Calcutta: A potential focus for an explosive HIV epidemic. Drug and Alcohol Review. 1997;16(1):17–23
  33. Panda S, Chatterjee A, Bhattacharjee S, Ray B, Saha MK, Bhattacharya SK. HIV, hepatitis B and sexual practices in the street-recruited injection drug users of Calcutta: Risk perception versus observed risks. International Journal of STD & AIDS. 1998;9(4):214–218
  34. Panda S, Saha U, Pahari S, Nathan M, Poddar S, Neogi D, et al. Drug use among the urban poor in Kolkata: Behaviour and environment correlates of low HIV infection. National Medical Journal of India. 2002;15(3):128–134
  35. Panda S, Kumar MS, Saravanamurthy PS, Mahalingam P, Vijaylakshmi A, Balakrishnan P, et al. Sexually transmitted infections and sexual practices in injection drug users and their regular partners in Chennai, India. Sexually Transmitted Diseases. 2007;34(4):250–253
  36. Peak A, Rana S, Maharjan SH, Jolley D, Crofts N. Declining risk of HIV among injecting drug users in Kathmandu, Nepal: The impact of a harm-reduction programme. AIDS. 1995;9(9):1067–1070
  37. Phipps W, Stanley H, Kohn R, Stansell J, Klausner JD. Syphilis, chlamydia, and gonorrhea screening in HIV-infected patients in primary care, San Francisco, California, 2003. AIDS Patient Care and STDs. 2005;19(8):495–498
  38. Platt L, Rhodes T, Judd A, Koshkina E, Maksimova S, Latishevskaya N, et al. Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities. American Journal of Public Health. 2007;97(3):478–485
  39. R Development Core Team. (2008). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN: 3-900051-07-0. Retrieved online May 16, 2008 at http://www.R-project.org.
  40. Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, et al. Prevalence of HIV, hepatitis C and syphilis among injection drug users in Russia: A multi-city study. Addiction. 2006;101(2):252–266
  41. Ross MW, Hwang LY, Zack C, Bull L, Williams ML. Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. International Journal of STD & AIDS. 2002;13(11):769–774
  42. Ruan Y, Chen K, Hong K, He Y, Liu S, Zhou F, et al. Community-based survey of HIV transmission modes among intravenous drug users in Sicuani, China. Sexually Transmitted Diseases. 2004;31:623–627
  43. Ruan Y, Cao X, Qian H, Zhang L, Qin G, Jiang Z, et al. Syphilis among female sex workers in southwest China: Potential for HIV transmission. Sexually Transmitted Diseases. 2006;33(12):719–723
  44. Rumi MAK, Siddiqui MA, Salam MA, Iqbal MR, Azam MG, Chowdhury AK, et al. Prevalence of infectious diseases and drug abuse among Bangladeshi workers. Southeast Asian Journal of Tropical Medicine & Public Health. 2000;31(3):571–574
  45. Scheinmann R, Hagan H, Lelutiu-Weinberger C, Stern R, Des Jarlais DC, Flom PL, et al. Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence. 2007;89:1–12
  46. Schwarzer, G. (2007). Meta: Meta-analysis. R package version 0.8-2. Retrieved online May 16, 2008 at http://cran.at.r-project.org/web/packages/meta/index.html.
  47. Steinbrook R. HIV in India—A complex epidemic. New England Journal of Medicine. 2007;356(11):1089–1093
  48. Strathdee SA, Philbin MM, Semple SJ, Pu M, Orozovich P, Martinez G, et al. Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug and Alcohol Dependence. 2008;92:132–140
  49. The World Bank. (2007). Data and statistics: Country groups. Retrieved online October 18, 2007 at http://go.worldbank.org/D7SN0B8YU0.
  50. Wai BH, Singh S, Varma SL. HIV infection in females dependent on drugs. Addiction. 1996;91:435–438
  51. Watters JK, Estilo MJ, Kral AH, Lorvick JJ. HIV infection among female injection-drug users recruited in community settings. Sexually Transmitted Diseases. 1994;21:321–328
  52. World Health Organization. (2001). Global prevalence and incidence of selected curable sexually transmitted infections overview and estimates. Retrieved online September 20, 2007 at http://www.who.int/docstore/hiv/GRSTI/index.htm.

PII: S0955-3959(09)00056-5

doi: 10.1016/j.drugpo.2009.02.008

International Journal of Drug Policy
Volume 21, Issue 1 , Pages 20-27 , January 2010

Article Tools

* Image Usage & Resolution